The effects of octreotide on healing of small bowel anastomosis

American Surgeon

Volumn 62, Issue 9, 1996, Pages 733-737

  Miller, Samuel K ^a   Martindale, Robert G ^b   Gao, Xiao X ^c   Gadacz, Thomas R ^a  

^a Departments of Surgery   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c Bayne Jones Army Community Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; HYDROCORTISONE; HYDROXYPROLINE; KININOGEN; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA SYNTHESIS; GASTRODUODENAL ULCER; HYPOTHESIS; INTESTINE ANASTOMOSIS; LIVER REGENERATION; LIVER RESECTION; MALE; NONHUMAN; RAT; WOUND HEALING;

ANASTOMOSIS, SURGICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG EVALUATION, PRECLINICAL; GASTROINTESTINAL AGENTS; HYDROCORTISONE; HYDROXYPROLINE; INTESTINE, SMALL; KININOGENS; MALE; OCTREOTIDE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TENSILE STRENGTH; WOUND HEALING;

EID: 0029761770     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Kokudo N, Kothary P, Eckhauser F, et al. Inhibition of DNA synthesis by somatostatin in rat hepatocytes stimulated by hepatocyte growth factor or epidermal growth factor. Am J Surg 1992;163:169-73.
2. Goldman A. Influence of somatostatin on hepatic regeneration in the adult rat. Surg Forum 1978;29:402-4.
3. Pruthi R, Farouk M, Tsai W, et al. The effect of octreotide on hepatic regeneration in rats. Surgery 1993; 113:84-9.
4. Bloom S, Polak J. The hormonal pattern of intestinal adaptation. Scand J Gastroenterol 1982;17(Suppl 74):93-103.
5. Conteas C, Majumdar A. The effects of gastrin, epidermal growth factor, and somatostatin on DNA synthesis in a small intestinal crypt cell line (IEC-6). Proc Soc Exp Biol Med 1987; 184:307-11.
6. Thompson J, Nguyen B, Harty F. Somatostatin analogue inhibits intestinal regeneration. Arch Surg 1993;128:385-9.
7. Bass B, Fischer B, Richardson C, Hormon J. Somatostatin analogue treatment inhibits postresectional adaptation of the small bowel in rats. Am J Surg 1991;161:107-12.
8. Tsuzaki S, Moses A. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cells. Endocrinology 1990;126:3131-8.
9. Lehy T, Dubrasquet M, Bonfils S. Effect of somatostatin on normal and gastic-stimulated cell proliferation in the gastric and intestinal mucosae of the rat. Digestion 1979;19:99-109.
10. Evers B, Parekh D, Townsend C, Thompson J. Somatostatin and analogues in the treatment of cancer. Ann Surg 1991;213: 190-8.
11. Hurst R, Modlin I. The therapeutic role of octreotide in the management of surgical disorders. Am J Surg 1991;162:499-507.
12. Konturek S, Dembinski A, Warzecha Z, et al. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988;94:1300-7.
13. Reiser K, Amigable M, Last J. Nonenzymatic glycation of type I collagen. J Biol Chem 1992;267:24207-16.
14. Greenbaum L, Howard E, Albus U, Lapp C, Gao X. T-kininogen, processing and functions. Agents Actions 1992; 38(Suppl):300-6.
15. Mann E, Croyle M, Lingrel J. Identification of sequences mediating interleukin-6 induction of a rat T kininogen gene. J Biol Chem 1991;266:16931-4.
16. Utsunomita I, Nagai S, Oh-ishi S. Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J Immunol 1991;147:1803-9.
17. Andexson K, Lingrel J. Differential regulation of rat T-kininogen by tumor necrosis factor and interleukin-6. Mol Endocrinol 1990;4:543-50.
18. Howard E, Thompson Y, Lapp C, Greenbaum L. Reduction of T-kininogen messenger RNA levels by dexamethasone in the adjuvant-treated rat. Life Sei 1990;46:411-7.
19. Newman JB, Lluis F, Townsend CM Jr. Somatostatin. In Thompson JC, Greeley GH Jr, Rayford PL, Townsend CM Jr, eds. Gastrointestinal Endocrinology. New York: McGraw-Hill Book Co., 1987, pp 286-99.
20. Ellison EC, Garner WL, Mekhjian HS, et al. Successful treatment of pancreatic ascites with somatostatin analog (SMS 201-995). Gastroenterology 1986;90:1405(abst).
21. Santiago WC, O'Dorisio TM, Kirn JG, et al. Pancreatic cholera syndrome: Effect of a synthetic somatostatin analog on intestinal water and ion transport. Ann Intern Med 1985;103: 363-7.
22. Ellison EC, O'Dorisio TM, Elkmmas E, et al. Long-acting somatostatin analog inhibits calcium and secretin stimulated gastrin release in the Zollinger-Ellison syndrome. Gastroenterology 1986;90:1405(abst).
23. Ellison EC, O'Dorisio TM, Sparks J, et al. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: Implications for the treatment of apudomas. Surgery 1986; 100:437-44.
24. Souquet JC, Sassolas G, Forichon J, et al. Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome. Cancer 1987; 59:1654-60.
25. Vinik AI, Tsai S, Moattari AR, Cheung P. Somatostatin analogue (SMS 201-995) in patients with gastrinomas. Surgery 1988;104:834-42.
26. Osei K, O'Dorisio TM. Malignant insulinoma: Effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones. Ann Int Med 1985:103:223-5.
27. Reubi JC. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth. Acta Endocrinol 1985;109: 108-14.
28. O'Dorisio TM, Gaginella TS, Mekhjian HS, et al. Somatostatin and analogues in the treatment of Vipoma. Ann NY Acad Sei 1988:527:528-35.
29. Juby LD, Burke DA, Axon ATR. Somatostatin analogue SMS 201-995 long term therapy for vipoma. Postgrad Med 1987; 63:287-9.
30. Kraenzlin ME, Ch'ng JLC, Wood SM, et al. Long-term treatment of a Vipoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology 1985;88:185-7.
31. Clements D, Elias E. Regression of metastatic Vipoma with somatostatin analogue SMS 201-995. Lancet 1985;1:874-5.
32. Boden G, Ryan IG, Eisenschmid BL, et al. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. N Engl J Med 1986;314:1686-9.
33. Altimari AF, Bhoopalan N, O'Dorisio T, et al. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome. Surgery 1986;100:989-95.
34. Ahlman H, Ahlund L, Dahlstrom A, et al. Use of somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome. Br J Cancer 1987:56:840-2.
35. Kvols LK, Moertel CG, O'Connell MJ, et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986:315:663-6.
36. Burroughs AK, McCormick PA, Hughes MD, et al. Randomized, double-blinded, placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990:99:1388-95.
37. Nubiola P, Badia JM, Marines-Rodenas F, et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995. Ann Surg 1989;210:56-8.
38. Rosen GH. Somatostatin and its analogs in the short bowel syndrome. Nutrition Clin Pract 1992;7:81-5.
39. Greer RJ, Richards WO, O'Dorisio TM, et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 1990;212:678-87.
40. Gray JL, Debas HT, Mulvihill SJ. Control of dumping symptoms by somatostatin analogue in patients after gastric surgery. Arch Surg 1991;126:1231-6.
41. Gullo L, Barbara L. Treatment of pancreatic pseudocysts with octreotide. Lancet 1991;338:540-1.
42. Bassi C, Falconi M, Lombard! D, et al. Prophylaxis of complications after pancreatic surgery: Results of a multicenter trial in Italy. Italian Study Group. Digestion 1994;55 Suppl 1:41-7.
43. Fiess H, Klempa I, Hermanek P, et al. Prophylaxis of complications after pancreatic surgery: Results of a multicenter trial in Germany. Digestion 1994;55 Suppl 1:35-40.
44. Wahren J, Feiig T. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet 1976;2: 1213-6.
45. Keller U, Perruchoud^A; Kayasséh L, Gyr N. Effect of therapeutic doses of somatostatin (SST) on splanchnic blood flow in man. Eur Soc Clin Invest, Rotterdam 1978.
46. Tyden G, Samnegard H, Thulin L, et al. Circulatory effects of somatostatin in anesthetized man. Acta Chir Scand 1979;145: 443-6.
47. Arnold R, Lankisch PG. Somatostatin and the gastrointestinal tract. Clin Gastroenterol 1980;9:733-53.
48. Reichlin S. Somatostatin (second of two parts). N Engl JMed 1983;309:1556-63.
49. Price BA, Jaffe BM, Zinner MJ. Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog. Gastroenterology 1985;88:80-5.
50. Ehrlich HP, Hunt TK. Effects of cortisone and vitamin A on wound healing. Ann Surg 1968;167:324-8.
51. Dostal GH, Gamelli RL. The differential effect of corticosteroids on wound disruption strength in mice. Arch Surg 1990; 125:636-40.